AKT1 and breast cancer: Rajput et al. (2015) reported novel multilamellar gold niosomes which were loaded with Akt-SiRNA and TQ and this nanoformulated delivery system had a promising activity against tamoxifen-resistant and Akt-overexpressing MCF7 breast cancer cells36.